Evidence map›Paper›PMID 40278431›Full record

ArticleNeurology international2025

Very Early Rehabilitation After Treatment with Intravenous Thrombolysis for Mild Acute Ischemic Stroke.

Rahul R Karamchandani, Liang Wang, Dale Strong, Alexis A Mulvaney, Jonathan D Clemente, Jeremy B Rhoten

Abstract read
In one paragraph

Article in Neurology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rahul R KaramchandaniDepartment of Neurology, Neurosciences Institute, Wake Forest University School of Medicine, Advocate Health, Charlotte, NC 28203, USA.ORCID 0000-0002-2111-5523
Liang WangClinical Quality Analytics, Advocate Health, Charlotte, NC 28203, USA.
Dale StrongClinical Quality Analytics, Advocate Health, Charlotte, NC 28203, USA.
Alexis A MulvaneyDepartment of Physical Therapy, Advocate Health, Charlotte, NC 28203, USA.ORCID 0009-0004-9168-095X
Jonathan D ClementeCharlotte Radiology, Neurosciences Institute, Advocate Health, Charlotte, NC 28203, USA.
Jeremy B RhotenNeurosciences Institute, Advocate Health, Charlotte, NC 28203, USA.ORCID 0000-0002-7753-2158

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesThe optimal timing of rehabilitation after acute ischemic stroke is unclear. We studied neurological outcomes and safety of early mobilization (EM) within 24 h for patients receiving intravenous thrombolysis.

methodsThis was a retrospective analysis of patients treated at a single Comprehensive Stroke Center from 6/2020-10/2024 with EM versus usual care. Patients were eligible for EM if they were treated with intravenous thrombolysis and had post-treatment National Institutes of Health Stroke Scale scores ≤ 5, and later, ≤10. Ordinal regression was performed to determine factors associated with a 90-day functional outcome benefit in the full cohort. Propensity scores were calculated for matched sample pairs to determine any shift towards better outcomes with EM.

resultsGroups of 165 and 73 patients were treated with EM and usual care, respectively. Treatment with EM was not associated with improved 90-day neurological outcome (odds ratio [OR] for higher mRS 0.746,

conclusionsMobilization within 24 h resulted in comparable rates of 90-day neurological function, symptomatic intracranial hemorrhage, and hospital length of stay in patients with mild ischemic stroke treated with intravenous thrombolysis. Future trials may further investigate the safety and efficacy of EM in alternate and larger patient cohorts.

Indexed as

early mobilityintravenous thrombolysismild acute ischemic strokerehabilitation

Identifiers

PMID40278431
PMCPMC12029658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.